Global Meningitis Vaccines Market
Overview:
Meningitis is an inflammation of the tissue layers that surround the brain and spinal cord (meninges) as well as the fluid-filled area between the meninges (subarachnoid space). Meningitis can be caused by bacteria, viruses, fungus, or non-infectious illnesses. Meningitis symptoms include headache, fever, and a stiff neck that makes lowering the chin to the chest difficult or impossible, though infants may not have a stiff neck and symptoms may differ in the elderly and individuals who use immune-suppressing medicines. Vaccination is a safe option to develop immunity against meningitis. Immunization of individuals most at risk of being infected helps to protect the individuals from meningitis, prevents its spread within communities, and eventually benefits the entire population. However, not all causes of meningitis and septicemia are vaccine preventable so being able to recognize the symptoms is important.
Global meningitis vaccines market is forecast to be valued at US$ 4,070.1 Mn in 2022 over the forecast period.
Click Here for Free Sample Copy (Use corporate email ID Get Higher Priority) @ https://www.coherentmarketinsights.com/insight/request-sample/5042
Impact of COVID-19:
The pandemic and strict lockdowns in several nations globally impacted the financial status of many businesses in all sectors, even the private healthcare sector. The pandemic also impacted supply chains in the healthcare industry, due to strict lockdown in many areas. Private healthcare has been impacted by the pandemic.
The pandemic had a negative impact on the global meningococcal vaccines market, due to the reduction in the rate of vaccination against meningitis. For instance, ScienceDirect published an article in June 2022, mentioned that the World Health Organization and its partners were monitoring the disruptions in vaccination campaigns against meningitis A, measles, typhoid, cholera, yellow fever and tetanus-diphtheria caused due to COVID-19 in May 2020. Finding of a study mentioned that 57% of the campaigns in 57 nations were postponed due to COVID-19, which means that in May 2020, 796 million vaccine doses were missed.
Furthermore, rising research and development being carried out for developing meningitis vaccine by the major players in market is estimated to boost growth of the global meningitis vaccines market over the forecast period. For instance, GlaxoSmithKline Plc., declared that patient dosing has already begun in the phase III of their clinical program which is investigating 5- in-1 meningitis (MenABCWY) vaccine candidate and comparing it with Bexsero and Menveo, licensed meningococcal vaccines. The phase 3 studies are being conducted on patient aged between 10-25 years from Europe, Canada, Turkey, Australia and the U.S.
𝐖𝐞 𝐎𝐟𝐟𝐞𝐫 𝐂𝐮𝐬𝐭𝐨𝐦𝐢𝐳𝐞𝐝 𝐑𝐞𝐩𝐨𝐫𝐭, 𝐂𝐥𝐢𝐜𝐤 @ https://www.coherentmarketinsights.com/insight/request-customization/5042
Drivers:
Rising vaccination campaigns for meningitis is anticipated to fuel growth of the global meningitis vaccines market over the forecast period. For instance, the government of Nigeria launched a vaccination campaign on a large scale for vaccinating children from 19 northern states in November 2019. This campaign will help in boosting immunity against meningitis and measles in children. This campaign was supported by the World Health Organization, the National Primary Health Care Development Agency and Gavi, the Vaccine Alliance this campaign reached out to almost 28 million children.
Key Takeaways:
- Global meningitis vaccines market is estimated to witness a CAGR of 6.4% over the forecast period, owing to growing approvals from regulatory bodies for meningitis vaccines. For instance, Sanofi, gained the European Commission approval for their MenQuadfi, in November 2020. This vaccine is used for immunization of individuals of 1 year and above in age against meningococcal disease which is caused due to Neisseria meningitidis serogroups A, W, C, and Y.
- The pneumococcal conjugate vaccine segment, on the basis of vaccines in the global meningitis vaccines market is estimated to witness significant growth during the forecast period, due to rising product approvals by regulatory bodies for meningitis vaccines. For instance, Merck & Co., Inc., gained European Commission approval for a pneumococcal 15-valent conjugate vaccine, VAXNEUVANCE, in December 2021. This vaccine indicated prevention of pneumonia caused due to Streptococcus pneumoniae in adults.
- The government segment, among distribution channels is estimated to witness robust growth in the global meningitis vaccines market during the forecast period, due to rising initiatives by the government of various nations to battle the disease. For instance, the government of Indonesia gained support from UNICEF, Gavi, the Vaccine Alliance, the Bill and Melinda Gates Foundation and many other partners brought about the pneumococcal conjugate vaccine around the nation and immunized almost 4.5 million children against pneumococcus bacteria
Key Players:
Key players active in the global meningitis vaccines market are CanSinoBIO, GlaxoSmithKline plc., Sinovac Biotech Co., Ltd., Pfizer Inc., Panacea Biotec Limited, Merck & Co., Inc., Espromed Bio, Incepta Pharmaceuticals Ltd., LG Chem, Walvax Biotechnology Co., Ltd., GlaxoSmithKline plc., Bharat Biotech., Serum Institute of India Pvt. Ltd., Chengdu Kanghua Biological Products, Incepta Pharmaceuticals Ltd., BIO MED, Vacsera, Eubiologics Co., Ltd and Zhi Fei Biological.
Avail Discount on various license types on Immediate Purchase @ https://www.coherentmarketinsights.com/insight/buy-now/5042
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Vaccine
- Market Snapshot, By Age Group
- Market Snapshots, By Distribution Channel
- Market Snapshot, By Country
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- PEST Analysis
- Epidemiology
- Vaccine Development Cycle
- Vaccine Types/Technology and Route of Administration
- Pricing Analysis
- Pipeline Analysis
- Brand Comparison Mapping
- Market Dynamics
- Global Meningitis Vaccines Market – Impact of Coronavirus (Covid-19) Pandemic
- Economic Impact
- COVID-19 Epidemiology
- Demand and Supply Analysis
- Global Meningitis Vaccines Market, By Vaccine, 2017 – 2030, (US$ Million)
- Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 – 2030
- Segment Trends
- Pneumococcal Conjugate Vaccine
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- Pneumococcal Polysaccharide Vaccine
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- Meningococcal Vaccine
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- Overview
- Global Meningitis Vaccines Market, By Age Group, 2017 – 2030, (US$ Million)
- Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 – 2030
- Segment Trends
- Infants
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- Adults
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- Overview
- Global Meningitis Vaccines Market, By Distribution Channel, 2017 – 2030, (US$ Million)
- Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 – 2030
- Segment Trends
- Government
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- Private
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- Overview
View Press Release: https://www.coherentmarketinsights.com/press-release/meningitis-vaccines-market-4321
About US:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837